Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Residual symptoms after partial remission: an important outcome in depression.

Paykel ES, Ramana R, Cooper Z, Hayhurst H, Kerr J, Barocka A.

Psychol Med. 1995 Nov;25(6):1171-80.

PMID:
8637947
2.

Remission and residual symptomatology in major depression.

Paykel ES.

Psychopathology. 1998;31(1):5-14.

PMID:
9500681
3.

[Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].

Mouchabac S, Ferreri M, Cabanac F, Bitton M.

Encephale. 2003 Sep-Oct;29(5):438-44. French.

PMID:
14615693
4.

[The association between disability and residual symptoms in depressive patients: a 3-month follow-up].

Ozyüksel B, Uluğ B.

Turk Psikiyatri Derg. 2007 Winter;18(4):323-32. Turkish.

5.

Remission and relapse in major depression: a two-year prospective follow-up study.

Ramana R, Paykel ES, Cooper Z, Hayhurst H, Saxty M, Surtees PG.

Psychol Med. 1995 Nov;25(6):1161-70.

PMID:
8637946
6.

Residual symptoms at remission from depression: impact on long-term outcome.

Kennedy N, Paykel ES.

J Affect Disord. 2004 Jun;80(2-3):135-44.

PMID:
15207926
7.

Subsyndromal depressive symptoms in patients with bipolar and unipolar disorder during clinical remission.

Vieta E, Sánchez-Moreno J, Lahuerta J, Zaragoza S; EDHIPO Group (Hypomania Detection Study Group).

J Affect Disord. 2008 Apr;107(1-3):169-74. Epub 2007 Sep 17.

PMID:
17870184
8.

[Patients with a complete or partial remission of Major Depressive Episode as part of Recurrent Major Depressive Disorder: description of ECLAIR study population].

Gérard A, Pélissolo A, Falissard B, Goussiaume G, Millet V.

Encephale. 2005 Mar-Apr;31(2):174-81. French.

PMID:
15959444
9.

Predictors of remission after electroconvulsive therapy in unipolar major depression.

Dombrovski AY, Mulsant BH, Haskett RF, Prudic J, Begley AE, Sackeim HA.

J Clin Psychiatry. 2005 Aug;66(8):1043-9.

PMID:
16086621
10.

The prevalence, clinical relevance, and public health significance of subthreshold depressions.

Judd LL, Schettler PJ, Akiskal HS.

Psychiatr Clin North Am. 2002 Dec;25(4):685-98. Review.

PMID:
12462855
11.

Life events, social support and marital relationships in the outcome of severe depression.

Paykel ES, Cooper Z, Ramana R, Hayhurst H.

Psychol Med. 1996 Jan;26(1):121-33.

PMID:
8643751
12.

Residual symptoms in depressed patients who respond acutely to fluoxetine.

Nierenberg AA, Keefe BR, Leslie VC, Alpert JE, Pava JA, Worthington JJ 3rd, Rosenbaum JF, Fava M.

J Clin Psychiatry. 1999 Apr;60(4):221-5.

PMID:
10221281
13.

Residual symptom recovery from major affective episodes in bipolar disorders and rapid episode relapse/recurrence.

Judd LL, Schettler PJ, Akiskal HS, Coryell W, Leon AC, Maser JD, Solomon DA.

Arch Gen Psychiatry. 2008 Apr;65(4):386-94. doi: 10.1001/archpsyc.65.4.386.

PMID:
18391127
14.

Eighteen months of drug treatment for depression: predicting relapse and recovery.

Mulder RT, Frampton CM, Luty SE, Joyce PR.

J Affect Disord. 2009 Apr;114(1-3):263-70. doi: 10.1016/j.jad.2008.08.002. Epub 2008 Sep 20.

PMID:
18805590
15.

Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorder.

Perlis RH, Nierenberg AA, Alpert JE, Pava J, Matthews JD, Buchin J, Sickinger AH, Fava M.

J Clin Psychopharmacol. 2002 Oct;22(5):474-80.

PMID:
12352270
16.

Residual symptoms in depressed patients after treatment with fluoxetine or reboxetine.

Nelson JC, Portera L, Leon AC.

J Clin Psychiatry. 2005 Nov;66(11):1409-14.

PMID:
16420078
17.

Prevention of relapse in residual depression by cognitive therapy: a controlled trial.

Paykel ES, Scott J, Teasdale JD, Johnson AL, Garland A, Moore R, Jenaway A, Cornwall PL, Hayhurst H, Abbott R, Pope M.

Arch Gen Psychiatry. 1999 Sep;56(9):829-35.

PMID:
12884889
18.

Use of pattern analysis to predict differential relapse of remitted patients with major depression during 1 year of treatment with fluoxetine or placebo.

Stewart JW, Quitkin FM, McGrath PJ, Amsterdam J, Fava M, Fawcett J, Reimherr F, Rosenbaum J, Beasley C, Roback P.

Arch Gen Psychiatry. 1998 Apr;55(4):334-43.

PMID:
9554429
19.

Developing brief scales for use in clinical practice: the reliability and validity of single-item self-report measures of depression symptom severity, psychosocial impairment due to depression, and quality of life.

Zimmerman M, Ruggero CJ, Chelminski I, Young D, Posternak MA, Friedman M, Boerescu D, Attiullah N.

J Clin Psychiatry. 2006 Oct;67(10):1536-41.

PMID:
17107244
20.

Supplemental Content

Support Center